Oncology Central

Is there an accurate biomarker test for thyroid cancer recurrence on the horizon?

0

Patients who are diagnosed with differentiated thyroid cancer (DTC) have favorable survival rates of over 90%; however, up to 30% of them develop recurrent disease leading to considerable morbidity [1]. Multiple prognostic systems have been developed for thyroid cancer, which are effective in predicting mortality, but not as effective in predicting recurrence [2].

To view restricted content, please:
Share:

Leave A Comment